Long‐term health benefit and economic return of time in range ( TIR ) improvement in individuals with type 2 diabetes

Documenti analoghi

• Long‐term cost‐effectiveness of tirzepatide for individuals with type 2 diabetes and comorbid obesity
  di: Man Tang, et al.
  Pubblicazione: (2025)
• Association between low cognitive performance and diabetes‐related health indicators across racial and ethnic groups in adults with diabetes
  di: Piaopiao Li, et al.
  Pubblicazione: (2024)
• Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes
  di: Jingchuan Guo, et al.
  Pubblicazione: (2024)
• Developing an automated algorithm for identification of children and adolescents with diabetes using electronic health records from the OneFlorida + clinical research network
  di: Piaopiao Li, et al.
  Pubblicazione: (2024)
• Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks
  di: Ahmad M. Rajab, et al.
  Pubblicazione: (2025)